oral glp 1 drugs in development Lilly is now pharma's top revenue company. It just got FDA approval for an GLP-1, but Wall Street isn't celebrating The challenge of developing oral
Description
Not as an aesthetic goal
While highly effective for weight loss and cardiometabolic protection, GLP-1RAs may contribute to lean mass reduction, highlighting the importance of monitoring muscle health during therapy
Deaths ( n = 60) in total occurred in the study, 25 (3%) in the tirzepatide arms and five (4%) in the insulin glargine arm (HR, 0.70
In the absence of head-to-head comparisons, indirect evidence across heterogeneous trial populations with placebo or inferior active comparators provides limited guidance for clinical decision-making
